This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Navigant Hires Former DOJ Healthcare Fraud Expert

Navigant (NYSE: NCI) announced today that Wendy Weiss, former Chief of the Civil Fraud Section of the U.S. Attorney’s Office, has joined the Los Angeles office as a Managing Director in the Healthcare and Life Sciences Disputes, Compliance and Investigations team. Weiss will work with clients in the healthcare industry to address their litigation, investigative and compliance challenges.

As Chief of the Civil Fraud Section for the United States Attorney’s Office (DOJ) for the Central District of California in Los Angeles, Weiss focused on the enforcement of Federal healthcare fraud and False Claims statutes. She also served as the Central District Office’s Civil Health Care Fraud Coordinator for eleven years. Within her new role, Weiss will utilize her regulatory knowledge and expertise detecting and reporting fraud to help clients within the healthcare landscape avoid and address compliance risks.

"Wendy joins the practice at a time when healthcare fraud and enforcement actions are growing in complexity and volume,” said Kevin Cornish, Managing Director and Leader of Navigant’s Healthcare and Life Sciences Disputes, Compliance and Investigations group. “Wendy’s deep experience in the healthcare industry and unique perspectives from the DOJ will bring a wealth of knowledge to clients in the areas of litigation, investigation and compliance.”

Weiss is a sought after speaker at conferences nationwide pertaining to healthcare compliance, the Federal False Claims Act, and Qui Tam actions. She has received numerous awards from the Department of Justice and the U.S. Department of Health and Human Services.

“It is an exciting time to join Navigant and this team,” said Weiss. “The current regulatory landscape continues to create challenges for clients in the healthcare industry, and I look forward to working with clients to address these issues and provide high value solutions.”

About Navigant

Navigant (NYSE: NCI) is a specialized, global expert services firm dedicated to assisting clients in creating and protecting value in the face of critical business risks and opportunities. Through senior level engagement with clients, Navigant professionals combine technical expertise in Disputes and Investigations, Economics, Financial Advisory and Management Consulting, with business pragmatism in the highly regulated Construction, Energy, Financial Services and Healthcare industries to support clients in addressing their most critical business needs. More information about Navigant can be found at www.navigant.com.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,191.01 -97.62 -0.53%
S&P 500 2,108.43 -8.96 -0.42%
NASDAQ 4,981.6210 -26.4750 -0.53%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs